Washington – An anti-Covid pill developed by Merck has proved effective in treating the disease, the US Food and Drug Administration said yesterday in a …

Washington – US pharmaceutical company Pfizer on Tuesday asked regulators to authorize its Covid pill after it was shown to cut hospitalization or death by …

Paris – Covaxin, the first Covid-19 vaccine developed in India, is “highly efficacious” and presents no safety concerns, according to a study published in the …

New York – Pfizer Inc’s experimental antiviral pill to treat Covid-19 cut by 89 per cent the chance of hospitalisation or death for adults at …

Washington – The US Food and Drug Administration yesterday strengthened regulations on breast implants, ordering that patients receive more safety information and review a checklist …

Paris – Treating high-risk Covid-19 patients with the antidepressant fluvoxamine may reduce the risk of prolonged hospitalisation by up to a third, a large-scale study …

Washington – Pfizer’s Covid-19 vaccine is more than 90 per cent effective in preventing symptomatic disease among children aged 5-to-11, the company said in a …

Paris – Alzheimer’s disease, the most common form of dementia, is characterised by brain lesions that can cause devastating memory loss and behavioural changes. It …

New England – The use of Pfizer Inc and German partner BioNTech SE’s widely used Covid-19 vaccine marginally increases the risk of heart inflammation, but …

Seoul – Satu kajian mendapati, individu yang dijangkiti varian Delta Covid-19 memiliki kandungan virus 300 kali lebih banyak berbanding varian asal, lapor portal berita MailOnline, …